MAZE
#2129
Maze Therapeutics, Inc. - Common Stock
26.5 7 USD
-0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.08%
Monthly Change
+6.71%
6 month change
-3.94%
Year Change
-40.99%
Previous Close
27.7 0
Open
27.5 4
Low
26.5 7
High
28.2 4
Financials
2026
Current report, 13 Aug 2026
Maze Therapeutics, Inc. current report, 13 August 2026
8-K
Current report, Q3 FY2026
Maze Therapeutics, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Maze Therapeutics, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Maze Therapeutics, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Maze Therapeutics, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Maze Therapeutics, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Maze Therapeutics, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Maze Therapeutics, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Maze Therapeutics, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Maze Therapeutics, Inc. current report, Q1 FY2026
8-K